#1 · 068270
Celltrion, Inc.9.75%
Compare RISE Bio TOP10 Active (0000Z0) holdings, returns, price versus NAV and estimated fund flows. See each data date on the page.
Returns are negative over every period shown. The premium/discount is within 0.5%, so the price tracks NAV closely.
12 of the last 59 sessions (20%) saw net inflows and 13 saw net outflows.
| Date | Estimated net flow |
|---|---|
| 2026-10-14 | — |
| 2026-10-13 | ₩0 |
| 2026-10-12 | ₩0 |
| 2026-10-08 | ₩0 |
| 2026-10-07 | ₩0 |
| 2026-10-06 | ₩0 |
| 2026-10-02 | ₩0 |
| 2026-10-01 | ₩0 |
| 2026-09-30 | ₩0 |
| 2026-09-29 | ₩0 |
| 2026-09-28 | ₩0 |
| 2026-09-23 | ₩0 |
| 2026-09-22 | ₩0 |
| 2026-09-21 | ₩0 |
| 2026-09-18 | ₩0 |
| 2026-09-17 | ₩0 |
| 2026-09-16 | ₩0 |
| 2026-09-15 | ₩0 |
| 2026-09-14 | ₩0 |
| 2026-09-11 | ₩0 |
| 2026-09-10 | ₩0 |
| 2026-09-09 | +₩427M |
| 2026-09-08 | -₩425M |
| 2026-09-07 | -₩865M |
| 2026-09-04 | ₩0 |
| 2026-09-03 | +₩423M |
| 2026-09-02 | ₩0 |
| 2026-09-01 | ₩0 |
| 2026-08-31 | ₩0 |
| 2026-08-27 | +₩950M |
| 2026-08-26 | -₩475M |
| 2026-08-25 | ₩0 |
| 2026-08-24 | ₩0 |
| 2026-08-21 | -₩906M |
| 2026-08-20 | +₩488M |
| 2026-08-19 | -₩468M |
| 2026-08-18 | -₩941M |
| 2026-08-14 | ₩0 |
| 2026-08-13 | +₩498M |
| 2026-08-12 | +₩493M |
| 2026-08-11 | +₩1.5B |
| 2026-08-10 | +₩522M |
| 2026-08-07 | +₩2.9B |
| 2026-08-06 | +₩479M |
| 2026-08-05 | ₩0 |
| 2026-08-04 | -₩1.9B |
| 2026-08-03 | ₩0 |
| 2026-07-31 | ₩0 |
| 2026-07-30 | +₩746M |
| 2026-07-29 | +₩386M |
| 2026-07-28 | -₩413M |
| 2026-07-27 | ₩0 |
| 2026-07-24 | -₩427M |
| 2026-07-23 | -₩440M |
| 2026-07-22 | ₩0 |
| 2026-07-21 | -₩1.7B |
| 2026-07-20 | ₩0 |
| 2026-07-16 | ₩0 |
| 2026-07-15 | -₩470M |
| 2026-07-14 | -₩891M |
The top 5 holdings make up 41.0% of the fund, and the top 10 67.5%. New additions as of this snapshot: YUHAN CORPORATION.
| # | Holding | Weight | Status |
|---|---|---|---|
| 1 | Celltrion, Inc. 068270 | 9.75% | |
| 2 | Alteogen Inc. 196170 | 8.77% | |
| 3 | OliX Pharmaceuticals, Inc. 226950 | 8.19% | |
| 4 | Hanmi Pharm. Co., Ltd. 128940 | 7.79% | |
| 5 | LigaChem Biosciences Inc. 141080 | 6.51% | |
| 6 | INGENIA Therapeutics Inc. 950260 | 6.18% | |
| 7 | ST PHARM CO., LTD. 237690 | 5.51% | |
| 8 | OSCOTECInc. 039200 | 4.97% | |
| 9 | HANALL BIOPHARMA CO.,LTD 009420 | 4.94% | |
| 10 | PROTEINA CO.,LTD. 468530 | 4.89% | |
| 11 | ABL Bio Inc. 298380 | 4.57% | |
| 12 | PharmaResearch Co., Ltd. 214450 | 4.55% | |
| 13 | D&D Pharmatech Inc. 347850 | 4.18% | |
| 14 | AbClon Inc. 174900 | 3.95% | |
| 15 | Rznomics Inc. 476830 | 3.49% | |
| 16 | Voronoi, Inc. 310210 | 2.89% | |
| 17 | LivsMed Inc. 491000 | 2.23% | |
| 18 | HANS BIOMED CORPORATION 042520 | 1.16% | |
| 19 | KRW Cash 010010 | 1.16% | |
| 20 | Peptron, Inc. 087010 | 1.11% | |
| 21 | YUHAN CORPORATION 000100 | 1.10% | NEW |
| 22 | Hugel, Inc. 145020 | 1.00% | |
| 23 | Orum Therapeutics, Inc. 475830 | 0.87% | |
| 24 | curacle co., ltd. 365270 | 0.24% |